Molecular Templates, Inc.
MTEMOTCHealthcare
$0.00
$-0.00(-0.00%)
Market Cap$658
P/E Ratio—
52W High$1.59
52W Low$0.000099999997
Molecular Templates, Inc. (MTEM) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MTEM · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $57.31M | $19.75M | $38.70M | $18.84M | $22.27M |
| Cost of Revenue | $6.91M | $7.80M | $6.70M | $92.97M | $50.52M |
| Gross Profit | $50.40M | $11.95M | $32.00M | ($74.12M) | ($28.25M) |
| Gross Margin %(computed) | 87.94% | 60.51% | 82.69% | -393.31% | -126.85% |
| Operating Expenses | |||||
| R&D Expenses | $48.88M | $82.42M | $84.67M | $92.97M | $50.52M |
| G&A Expenses | $18.90M | $26.20M | $34.11M | $26.72M | $20.08M |
| Total Operating Expenses | $63.09M | $108.63M | $118.77M | $26.72M | $42.20M |
| Operating Income | ($10.47M) | ($88.87M) | ($80.07M) | ($100.84M) | ($70.45M) |
| Operating Margin %(computed) | -18.26% | -449.89% | -206.93% | -535.11% | -316.34% |
| Interest Income | $1.21M | $0.99M | $0.43M | $1.03M | $2.32M |
| Interest Expense | $2.65M | $4.72M | $3.37M | $1.71M | $1.30M |
| Income Before Tax | ($8.13M) | ($92.67M) | ($83.01M) | ($104.91M) | ($69.42M) |
| Income Tax Expense | ($0.01M) | $0.05M | $0.00M | $0.01M | $0.00M |
| Net Income | ($8.12M) | ($92.72M) | ($83.01M) | ($104.92M) | ($69.42M) |
| Net Margin %(computed) | -14.18% | -469.36% | -214.51% | -556.73% | -311.72% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.80 | $-24.75 | $-22.50 | $-33.06 | $-27.62 |
| Wtd Avg Shares | 4.50M | 3.76M | 3.69M | 3.17M | 2.52M |
| EBITDA | $1.16M | ($80.15M) | ($72.94M) | ($99.01M) | ($66.02M) |
| EBITDA Margin %(computed) | 2.03% | -405.74% | -188.49% | -525.37% | -296.47% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Molecular Templates, Inc. data
About Molecular Templates, Inc. (MTEM) Income Statement
Molecular Templates, Inc. (MTEM) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2023, MTEM reported revenue of $0.06B, gross profit of $0.05B (gross margin 87.94%), and net income of ($0.01B) — a net profit margin of -14.18%.
Frequently asked questions
MTEM · 4 questionsMolecular Templates, Inc. (MTEM) reported revenue of $0.06B for 2023, up 190.1% year-over-year.
MTEM revenueMTEM salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09